PATENT CLAIM ANALYSIS

Application Number: 16212667
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "397000"]

Abstract:
The addition of a salt to an ALA formulation that is dissolved in the mouth unexpectedly significantly reduces the degree of burning or irritation from ALA exposure during administration. This invention is particularly useful for an oral dissolved form of administration due to the extended time of ALA exposure that is possible with such formulations. The salt-inclusive formulations of the invention can increase efficacy of the ALA administration, reduce negative side effects, or both.

Claim (Index 18):
The method of  claim 9 , wherein the alpha-lipoic acid comprises a single enantiomer of alpha lipoic acid.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 98.0
- Lexical Diversity: 1.54902
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13602093', '14772035', '10997519', '14775959', '13719640']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6939113233641414
- 35 USC 102 Novelty (BERT): 0.490465802958792
- Combined Prediction Score: 0.6735667713236064
- Mean Citation Score: 128.892178
- Max Citation Score: 159.75322
- Similarity Product: 103.78047640455009

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test